BUVALOR 10
Manufacturer Details- Buprenorphine - @ Narcotic agonist analgesics- (FDC-List)- (Dec 2008)
Compositions:
Buprenorphine transdermal patch containing buphrenophine EP 5mg/10mg/20mg with a nominal release rate of 5mcg/h /10mcg/h/20mcg/h over a period of 7 days, Area containing active substance 6.25 cm2/12.5cm2/25cm2,
List of Related Indications:
Buprenorphine transdermal patch containing buphrenophine EP 5mg/10mg/20mg with a nominal release rate of 5mcg/h /10mcg/h/20mcg/h over a period of 7 days, Area containing active substance 6.25 cm2/12.5cm2/25cm2,
- Severe pain
| Strength | Rate | Packing Style |
|---|---|---|
| 5mcg/h /10mcg/h | 0.00 | each patch |
